Cargando…
Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity
BACKGROUND: Acute myeloid leukemia mainly affects adult patients. Complete remission for patients younger than 60 years, who are candidates for standard induction therapy, is achieved in 60%–80% of cases. However, the prognosis is still poor for older patients, who are unfit for intensive chemothera...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440450/ https://www.ncbi.nlm.nih.gov/pubmed/30988610 http://dx.doi.org/10.2147/IJN.S190482 |